SCHEMBL477067

SCHEMBL477067

C1CCCCC(N2CCCCCNCC2)CCC1

nearest known ligand 0.79

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.67
KMT2A Q03164 2/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
ALDH1A1 P00352 1/20 0.39
L3MBTL3 Q96JM7 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
PHGDH O43175 1/20 0.37
MGLL Q99685 1/20 0.37
SLC18A3 Q16572 1/20 0.36
OPRM1 P35372 2/20 0.36
OPRD1 P41143 1/20 0.36
OPRK1 P41145 1/20 0.36
OGFRL1 Q5TC84 1/20 0.36
MEN1 O00255 1/20 0.36
OPRL1 P41146 1/20 0.36
PDE7A Q13946 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL455527 1.00 HTR6 (0.67) HTR6KMT2AHPGDSMN1; SMN2HRH3
SCHEMBL28008874 1.00 HTR6 (0.67) HTR6KMT2AHPGDSMN1; SMN2HRH3
Fluoride SCHEMBL28240221 0.98 HTR6 (0.64) HTR6KMT2AHPGDSMN1; SMN2HRH3
Hydrochloric Acid SCHEMBL11395977 0.98 HTR6 (0.64) HTR6KMT2AHPGDSMN1; SMN2HRH3
Ammonia Solution, Strong SCHEMBL11389061 0.98 HTR6 (0.64) HTR6KMT2AHPGDSMN1; SMN2HRH3
SCHEMBL29835975 0.96 HTR6 (0.62) HTR6KMT2AHPGDSMN1; SMN2HRH3
Hydrochloric Acid SCHEMBL11443374 0.96 HTR6 (0.62) HTR6KMT2AHPGDSMN1; SMN2HRH3
SCHEMBL3689659 0.96 HTR6 (0.59) HTR6KMT2AHRH3ALDH1A1L3MBTL3
SCHEMBL25639610 0.96 HTR6 (0.59) HTR6KMT2AHRH3ALDH1A1L3MBTL3
SCHEMBL8884589 0.94 HTR6 (0.60) HTR6KMT2AHPGDSMN1; SMN2HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2331546-B1 2-ALKYL-6-CYCLOAMINO-3-(PYRIDIN-4-YL)IMIDAZO[1,2-IB]-PYRIDAZINE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC APPLICATION THEREOF SANOFI SA (FR) 2012-02-01 EP claimed
US-20110312934-A1 2-ALKYL-6-CYCLOAMINO-3-(PYRIDIN-4-YL)IMIDAZO[1,2-B]-PYRIDAZINE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC APPLICATION THEREOF SANOFI-AVENTIS (FR) 2011-12-22 US claimed
US-4921855-A New Histidyl amino acid derivatives, and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-05-01 US claimed
US-20110312934-A1 2-ALKYL-6-CYCLOAMINO-3-(PYRIDIN-4-YL)IMIDAZO[1,2-B]-PYRIDAZINE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC APPLICATION THEREOF SANOFI-AVENTIS (FR) 2011-12-22 US disclosed
EP-1032613-B1 REACTIVE DISAZO DYES DYSTAR TEXTILFARBEN GMBH & CO (DE) 2003-02-19 EP disclosed
US-6191264-B1 DYEBASE A CENTRAL 1-HYDROXY-8-AMINONAPHTHALENESULFONIC ACID WITH TERMINAL BENZENE NUCLEI EACH WITH A REACTIVE TRIAZINYLAMINO GROUP, AT LEAST ONE OF WHICH HAS ON THE TRIAZINYL NUCLEUS A CARBAMOYL ALKYLAMINO GROUP BASF AKTIENGESELLSCHAFT (DE) 2001-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312934-A1 2-ALKYL-6-CYCLOAMINO-3-(PYRIDIN-4-YL)IMIDAZO[1,2-B]-PYRIDAZINE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC APPLICATION THEREOF NR3C1, CNKSR1, NR3C2 HTR6 382/4885KMT2A 3677/4885HPGD 2248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.